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Objective: Knee osteoarthritis (OA) is a major public health issue causing chronic pain and disability.
However, there is little information on the impact of this disease on quality of life (QOL) in Japanese men
and women. The objective of the present study was to clarify the impact of radiographic and symp-
tomatic knee OA on QOL in Japan.
Methods: This study examined the association of radiographic and symptomatic knee OA with QOL
parameters such as the Medical Outcomes Study Short Form-8 (SF-8), EuroQOL (EQ-5D) and Western
Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Radiographic knee OA was deﬁned
according to Kellgren/Lawrence (KL) grades, and symptomatic knee OA was deﬁned as KL¼ 3 or 4 with
knee pain. We also examined the independent association of symptomatic knee OA and grip strength
with QOL.
Results: From the 3040 participants in the Research on Osteoarthritis Against Disability (ROAD) study, the
present study analyzed 2126 subjects older than 40 years who completed the questionnaires (767 men
and 1359 women; mean age, 68.9 10.9 years). Subjects with KL¼ 3 or 4 had signiﬁcantly lower physical
QOL as measured by the physical component summary (PCS) score of the SF-8 and pain domains of the
WOMAC, whereas mental QOL, as measured by the mental component summary (MCS) score of the SF-8,
was higher in subjects with KL¼ 3 or 4 than KL¼ 0 or 1. Symptomatic knee OA was signiﬁcantly more
likely than radiographic knee OA without pain to be associated with physical QOL loss as measured by
the PCS score and physical domains of the WOMAC. Symptomatic knee OA and grip strength were
independently associated with physical QOL.
Conclusion: This cross-sectional study revealed that subjects with symptomatic knee OA had signiﬁcantly
lower physical QOL than subjects without it.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is a major public health issue that
causes chronic pain and disability1e3. The prevalence of radio-
graphic knee OA is high in Japan4, with 25,300,000 subjects aged 40: Shigeyuki Muraki, Depart-
ntury Medical and Research
o, Hongo 7-3-1, Bunkyo-ku,
-3-5800-9179.
uraki).
s Research Society International. Pyears and older estimated to experience radiographic knee OA5.
According to the recent National Livelihood Survey of the Ministry
of Health, Labour and Welfare in Japan, OA is ranked fourth among
diseases that cause disabilities that subsequently require support
with activities of daily living6.
Quality of life (QOL) measurements in patients with chronic
diseases are useful tools for estimating disease impact; these QOL
scales may be generic or disease speciﬁc. Among the generic scales,
the EuroQOL (EQ-5D) has been widely used to measure health-
related QOL (HRQOL) in patients with OA7,8, and several studies
have used the Medical Outcomes Study Short Form-36 (SF-36) inublished by Elsevier Ltd. All rights reserved.
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studies include only patients with knee OA, and there are few
population-based studies regarding knee OA and QOL11. A previous
population-based study in Caucasians showed that arthritis has
a major impact on the HRQOL measured by the SF-36 in
a community setting11, although arthritis was examined by self-
reportedmeans and not by radiographs. In terms of disease-speciﬁc
scales for knee OA, the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) has been used for Caucasians12 and
Asians13,14, although these reports were not population-based
studies. Furthermore, there is little information on the impact of
knee OA with QOL in Japan, although a population survey suggests
that the disease pattern differs among races15e17. In fact, the
prevalence of knee OA in Japan4 was much higher than that of
previous epidemiologic studies in elderly Caucasians16,18. Further-
more, in terms of risk factors, studies in Caucasians have suggested
that occupational activities that include kneeling and squatting
were associated with knee OA19, whereas these activities were not
associated with Kellgren/Lawrence (KL) grades 2 OA in our
previous study in Japan20. Therefore, the impact of knee OA on QOL
also appears to differ in different populations. It would thus be of
interest to clarify the impact of OA on QOL in a Japanese population.
The principal clinical symptom of knee OA is pain21, but the
correlation with the radiographic severity of knee OA is con-
troversial4,22e24. Thus it would be interesting to determinewhether
the impact of radiographic knee OA on QOL differs according to the
severity of OA. Furthermore, pain is strongly associated with QOL,
so it would be of interest to clarify the impact of symptomatic OA as
well as radiographic knee OA on QOL.
Gender differences have also been observed in knee OA. The
prevalence of knee OA is higher in women than men4, and the
association of knee painwith knee OA also differs by gender4. Thus,
the impact of these diseases on QOL may also differ between
genders. However, to the best of our knowledge, there are no
population-based studies that assess the association of knee OA
with QOL in men and women separately.
Grip strength is a useful marker of muscle function and sarcope-
nia25. There is growing evidence that reduced grip strength is asso-
ciated with adverse outcomes including morbidity26, disability27,
falls27, higher fracture rates28, increased length of hospital stay29, and
mortality27. A previous studyalso showed that grip strength is related
to total muscle strength30. Furthermore, there is increasing recogni-
tion that grip strength is a useful clinical marker of sarcopenia, and
recent work has validated this approach, demonstrating that grip
strength ismore strongly associatedwith age and is a better predictor
of poor mobility than other potential markers such as calf muscle
area31. Previous reports have shown that low muscle mass was also
associated with reduced QOL32,33; thus, the association of knee OA
with QOL may be inﬂuenced by grip strength, but again, no studies
have examined theassociationof kneeOAandgrip strengthwithQOL
simultaneously in the same population.
The ﬁrst objective of this study is to clarify the association of
radiographic severityof kneeOAwithQOL among Japanesemen and
women using the large-scale, population-based cohort study called
the Research on Osteoarthritis Against Disability (ROAD). Because
pain is strongly associated with QOL, we also examined the associ-
ation of symptomatic knee OA with QOL. Finally, we analyzed the
independent associations of knee OA and grip strength with QOL.
Subjects and methods
Subjects
The ROAD study is a nationwide prospective study designed to
establish epidemiologic indexes for evaluation of clinical evidencefor the development of a disease-modifying treatment for bone and
joint diseases (with OA and osteoporosis as the representative bone
and joint diseases). It consists of population-based cohorts in
several communities in Japan. A detailed proﬁle of the ROAD study
has been described in detail elsewhere4,5,34; a brief summary is
provided here. To date, we have completed creation of a baseline
database including clinical and genetic information for 3040
inhabitants (1061 men and 1979 women) ranging in age from 23 to
95 years (mean, 70.6 years), who were recruited from resident
registration listings in three communities: an urban region in Ita-
bashi, Tokyo, amountainous region in Hidakagawa,Wakayama, and
a seacoast region in Taiji, Wakayama. All participants provided
written informed consent, and the study was conducted with the
approval of the ethics committees of the University of Tokyo and
the Tokyo Metropolitan Institute of Gerontology. Anthropometric
measurements included height and weight, and body mass index
(BMI) (weight [kg]/height2 [m2]) was calculated. Grip strength was
measured on bilateral sides using a TOEI LIGHT handgrip dyna-
mometer (TOEI LIGHT Co., Ltd, Saitama, Japan), and the better
measurement was used to characterize maximummuscle strength.
Among 2995 subjects aged 40 years or older in the ROAD study,
2243 (74.9%), 2245 (75.0%) and 2222 (74.2%) subjects completed
the SF-8, the EQ-5D and theWOMAC, respectively, and 2126 (71.0%)
subjects completed all three questionnaires. The present study
analyzed 2126 subjects (767 men and 1359 women) aged 40 years
(mean, 68.910.9 years) or older who had completed the SF-8, the
EQ-5D, and the WOMAC.
Radiographic assessment
All participants had radiographic examination of both knees
using anterioreposterior and lateral views with weight-bearing
and foot map positioning. Knee radiographs were read without
knowledge of participant clinical status by a single well-experi-
enced orthopaedist (SM) using the KL radiographic atlas for overall
knee radiographic grades35. In KL grade, radiographs are scored as
grade 0 through 4, with higher grades being associated with more
severe OA. The higher KL grade in both knees was designated as
that of the participant. Symptomatic knee OA was deﬁned as: (1)
a subject reporting knee pain lasting at least 1 month with pain
having last occurred within the current or previous year; and (2)
KL¼ 3 or 4 OA in the painful knee. To evaluate the intra-observer
variability of KL grading, 100 randomly selected radiographs of the
knee were scored by the same observer more than 1 month after
the ﬁrst reading. One hundred other radiographs were also scored
by two experienced orthopaedic surgeons (SM & HO) using the
same atlas for inter-observer variability. The evaluated intra- and
inter-observer variabilities were conﬁrmed by kappa analysis to be
sufﬁcient for assessment (0.86 and 0.80, respectively).
Instruments
The SF-8 generates a health proﬁle consisting of eight scales and
two summary measures describing HRQOL. The SF-8 is an alternate
form to the SF-36, which is the most widely used patient-based
health status survey, translated into more than 40 languages; the
Japanese version of the SF-36 has been well validated36. The SF-8
uses a single question to measure each of the eight SF-36 domains.
In the SF-8, each of the eight items assesses a different dimension of
health: General Health (GH), Physical Functioning (PF), Role Phys-
ical (RP), Bodily Pain (BP), Vitality (VT), Social Functioning (SF),
Mental Health (MH) and Role Emotional (RE). The SF-8 was scored
by assigning the mean SF-36 scale score from the 2002 general
Japanese population to each response category of the SF-8
measuring the same concept, and thenweighting each SF-8 item to
Table I
Characteristics of participants
Overall Men Women P-Values
Number of subjects 2126 767 1359
Age, years 68.9 10.9 69.7 10.5 68.4 11.1 0.006
Height, cm 154.6 9.2 162.8 6.7 150.0 6.9 <0.0001
Weight, kg 55.0 10.9 61.5 10.8 51.4 9.0 <0.0001
BMI, kg/m2 22.9 3.6 23.1 3.4 22.8 3.7 0.03
Grip strength, kg 25.5 9.3 33.2 8.9 21.2 6.3 <0.0001
Radiographic knee OA, % 17.9 11.6 21.5 <0.0001
Symptomatic knee OA, % 9.0 5.0 11.3 <0.0001
SF-8
PCS 47.0 7.0 47.4 6.8 46.8 7.0 0.03
MCS 52.8 5.9 53.4 5.3 52.5 6.1 0.0009
EQ-5D 0.90 0.15 0.91 0.14 0.90 0.15 0.03
WOMAC
Pain (0e20) 1.37 2.44 1.13 2.16 1.50 2.57 0.0003
Stiffness (0e8) 0.71 1.25 0.63 1.09 0.77 1.33 0.01
Function (0e68) 4.08 7.93 3.35 7.06 4.49 8.37 0.001
Except where otherwise indicated, values are the mean SD.
The differences between men and women were examined by the Student’s t test
except for the prevalence of radiographic and symptomatic knee OA.
The prevalence of radiographic and symptomatic knee OA was compared between
men and women using the chi-square test.
Radiographic knee OA was deﬁned as KL grade 3 or 4.
Symptomatic knee OA was deﬁned as KL grade 3 or 4 with knee pain.
SF-8, Medical Outcomes Study Short Form-8.
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mental component summary (MCS) scores. The SF-8 may be scored
using a published algorithm for Japanese versions of the SF-8,
which has been well validated37. The EQ-5D self-report
questionnaire measures ﬁve domains of HRQOL, includingmobility,
self-care, usual activities, pain/discomfort, and anxiety/depres-
sion38. Each of the ﬁve domains is assessed by a single question
with three response levels (no problem, some problems, and
extreme problems), so the EQ-5D deﬁnes a total of 243 health
states. These results were coded and converted to a score of utility
using the tables of values39. The EQ-5D scoring algorithm was ﬁrst
developed using time trade off-based preference scores for
a sample of these health states from a representative sample of the
UK general population38; the Japanese version of the EQ-5D has
been validated39. This EQ-5D algorithm is used worldwide and
generates scores ranging from0.111 to 1.000, with negative scores
representing health states worse than being dead, 0 representing
being dead, and 1.00 representing a state of full health. The
WOMAC, a 24-item OA-speciﬁc index, consists of three domains:
pain, stiffness, and physical function. Each of these 24 items is
graded on either a ﬁve-point Likert scale or a 100-mm visual
analogue scale12,40. In the present study, we used the Likert scale
(version LK 3.0). The domain score ranges from 0 to 20 for pain, 0 to
8 for stiffness, and 0 to 68 for physical function. Japanese versions of
the WOMAC have also been validated41.
Statistical analysis
The differences in age, height, weight, BMI, grip strength, and
QOL measurements between men and women were examined by
the Student’s t test. The prevalence of radiographic and symp-
tomatic knee OA was compared between men and women using
the chi-square test. We also used the chi-square test to analyze
whether subjects with one symptomatic knee were likely to have
symptomatic OA in the other knee. According to KL grade35, KL¼ 2
was deﬁned as deﬁnite osteophytosis but no deﬁnite joint space
narrowing, and KL¼ 3 and 4 included deﬁnite joint space nar-
rowing. We thus categorized KL grade in KL¼ 0 or 1, KL¼ 2, or
KL¼ 3 or 4, and differences among each KL grade with QOL
measurements were determined using the Tukey Honestly Signif-
icant Difference (HSD) test without adjustment and after adjust-
ment for age, BMI, and grip strength in men and women. We
further classiﬁed subjects into those with symptomatic knee OA,
those with KL¼ 3 or 4 knee OA without pain, and those without
KL¼ 3 or 4 knee OA, and compared their associationwith QOL using
the Tukey HSD test after adjustment for age, BMI, and grip strength.
To determine the independent association of symptomatic knee OA
and grip strength with QOL, we used multiple regression analysis
without adjustment and after adjustment for age and BMI. Data
analyses were performed using SAS version 9.0 (SAS Institute Inc.,
Cary, NC).
Results
The characteristics of the 2126 participants in the present study
are shown in Table I. The prevalence of knee OA was signiﬁcantly
higher in women than men. The prevalence of bilateral and
unilateral symptomatic knee OA was 2.0% and 3.0% in men, and
5.6% and 5.8% in women, respectively. Chi-square test showed that
when the right knee had symptomatic knee OA, the odds ratio for
the left knee to have symptomatic knee OA was 86.3 and 59.7 in
men andwomen, respectively. The PCS andMCS of the SF-8 and the
EQ-5D utility scores were signiﬁcantly higher and the all domains
ofWOMACwere signiﬁcantly lower in men thanwomen, indicating
that the QOL scores were higher in men than women.The scores for PCS and MCS in the SF-8, the EQ-5D utility scores,
and all domains in the WOMAC by KL grade of knee OA in men and
women are shown in Tables II and III. The associations of age, BMI,
and grip strength with each QOL parameter were signiﬁcant in men
and women by linear regression analysis (P< 0.01), except for the
association of age with the MCS of the SF-8. Thus, we used the
Tukey HSD test after adjustment for age, BMI, and grip strength to
determine the association of radiographic severity of knee OA with
QOL. Men and womenwith KL¼ 3 or 4 had signiﬁcantly lower QOL
measured by PCS of the SF-8 and pain domains of theWOMAC than
those with KL¼ 0 or 1 as well as KL¼ 2. In addition, the MCS scores
were higher in men and women with KL¼ 3 or 4 compared with
KL¼ 0 or 1. The EQ-5D utility scores were not signiﬁcantly associ-
ated with the KL grade of the knee after adjustment for age, BMI
and grip strength.
Next, to determine impact of symptoms of radiographic knee OA
with QOL, we classiﬁed subjects into those with symptomatic knee
OA, deﬁned as KL¼ 3 or 4 with knee pain, those with KL¼ 3 or 4
without pain, and those without KL¼ 3 or 4 and compared the
impact of each type of OA on QOL using the Tukey HSD test after
adjustment for age, BMI, and grip strength (Fig. 1). In men and
women, PCS of the SF-8 and physical function domain of the
WOMAC were signiﬁcantly lower in subjects with symptomatic
knee OA compared with those without KL¼ 3 or 4 knee OA (men:
difference in mean 5.9, 95% CI 8.6 to 3.2 and difference in
mean 4.9, 95% CI 2.2 to 7.6, respectively; women: difference in
mean 4.3, 95% CI 5.7 to 2.9 and difference in mean 3.9, 95% CI
2.3 to 5.5, respectively) as well as KL¼ 3 or 4 knee OAwithout pain
(men: difference in mean 6.3, 95% CI 9.7 to 3.0 and difference
in mean 5.7, 95% CI 2.3 to 9.1, respectively; women: difference in
mean 4.9, 95% CI 6.7 to 3.1 and difference in mean 3.9, 95% CI
1.8 to 5.9, respectively), whereas among thosewith KL¼ 3 or 4 knee
OA without pain and no KL¼ 3 or 4 knee OA, there were no
signiﬁcant differences in PCS of the SF-8 and physical function
domain of the WOMAC. In women, MCS of the SF-8 was signiﬁ-
cantly higher in subjects with symptomatic knee OA compared
with thosewithout KL¼ 3 or 4 knee OA (difference inmean 2.6, 95%
CI 1.3 to 4.0) as well as KL¼ 3 or 4 knee OAwithout pain (difference
in mean 2.3, 95% CI 0.6 to 4.0). The EQ-5D utility score was
Table II
Mean scores of the SF-8, EQ-5D, and WOMAC scales by KL grade in men
Severity of knee OA Difference in means (95% CI)
KL¼ 0 or 1 (n¼ 444) KL¼ 2 (n¼ 231) KL¼ 3 or 4 (n¼ 92) KL¼ 3 or 4 vs KL¼ 0 or 1 KL¼ 3 or 4 vs KL¼ 2
SF-8
PCS Crude 48.1 0.3 47.1 0.4 44.7 0.7 3.3 (5.2, 1.5) 2.3 (4.3, 0.4)
Adjusted 47.8 0.3 47.4 0.4 45.5 0.7 2.3 (4.2, 0.5) 1.9 (3.9, 0.0)
MCS Crude 52.8 0.2 53.7 0.3 55.3 0.5 2.5 (1.1, 3.9) 1.6 (0.1, 3.1)
Adjusted 52.9 0.3 53.7 0.4 55.2 0.6 2.3 (0.8, 3.8) 1.5 (0.02, 3.1)
EQ-5D Crude 0.92 0.01 0.91 0.01 0.87 0.01 0.06 (0.10, 0.02) 0.04 (0.08, 0.00)
Adjusted 0.92 0.01 0.91 0.01 0.89 0.01 0.03 (0.07, 0.01) 0.03 (0.07, 0.01)
WOMAC
Pain Crude 0.92 0.10 1.13 0.14 2.11 0.22 1.19 (0.61, 1.76) 0.97 (0.36, 1.59)
Adjusted 1.03 0.10 1.02 0.14 1.75 0.22 0.72 (0.14, 1.30) 0.73 (0.12, 1.34)
Stiffness Crude 0.57 0.05 0.65 0.07 0.91 0.11 0.34 (0.05, 0.64) 0.26 (0.05, 0.58)
Adjusted 0.60 0.05 0.61 0.07 0.80 0.12 0.20 (0.10, 0.50) 0.19 (0.13, 0.51)
Function Crude 2.83 0.33 3.38 0.46 6.08 0.73 3.24 (1.36, 5.12) 2.70 (0.67, 4.73)
Adjusted 3.31 0.32 2.88 0.45 4.66 0.72 1.35 (0.53, 3.23) 1.77 (0.19, 3.74)
Values are mean standard error (SE). SF-8, Medical Outcomes Study Short Form-8.
Adjusted differences in means were calculated by Tukey HSD test after adjustment for age, BMI and grip strength.
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compared with those without KL¼ 3 or 4 knee OA (difference in
mean 0.08, 95% CI 0.13 to 0.02) as well as KL¼ 3 or 4 knee OA
without pain in men (difference in mean 0.08, 95% CI 0.15 to
0.01), but not in women.
Next, to examine the independent association of symptomatic
knee OA and grip strength on QOL, multiple regression analysis was
used with age, BMI, grip strength, and the presence of symptomatic
knee OA as independent variables (Table IV). In men and women,
symptomatic knee OA and grip strength were independently
associated with PCS of the SF-8 (R2, 0.11 and 0.17, respectively),
EQ-5D utility scores (R2, 0.08 and 0.12, respectively), and pain
(R2, 0.12 and 0.16, respectively), stiffness (R2, 0.06 and 0.09,
respectively) and physical function domains (R2, 0.13 and 0.21,
respectively) of the WOMAC.
Discussion
This is the ﬁrst study to examine the association of radiographic
and symptomatic knee OA with QOL measured by generic scales
such as the SF-8, which is an alternate form of the SF-36, and the
EQ-5D, as well as a disease-speciﬁc scale such as WOMAC inTable III
Mean scores of the SF-8, EQ-5D, and WOMAC scales by KL grade in women
Severity of knee OA
KL¼ 0 or 1 (N¼ 541) KL¼ 2 (N¼ 526) K
SF-8
PCS Crude 48.4 0.3 46.9 0.3 4
Adjusted 47.1 0.3 47.4 0.3 4
MCS Crude 52.1 0.3 52.3 0.3 5
Adjusted 51.9 0.3 52.5 0.3 5
EQ-5D Crude 0.92 0.01 0.89 0.01 0
Adjusted 0.89 0.01 0.91 0.01 0
WOMAC
Pain Crude 0.96 0.11 1.45 0.10 2
Adjusted 1.45 0.11 1.19 0.11 1
Stiffness Crude 0.55 0.06 0.79 0.06 1
Adjusted 0.75 0.06 0.68 0.06 0
Function Crude 2.41 0.34 4.54 0.35 8
Adjusted 4.37 0.35 3.62 0.33 5
Values are mean SE. SF-8, Medical Outcomes Study Short Form-8.
Adjusted differences in means were calculated by Tukey HSD test after adjustment for aJapanese men and women using a large-scale population-based
cohort study. In the present study, subjects with KL¼ 3 or 4 had
signiﬁcantly lower physical QOL than those with KL¼ 0 or 1 as well
as KL¼ 2. At the same time, theMCS scores were higher in KL¼ 3 or
4 than KL¼ 0 or 1 in men and women. Furthermore, symptomatic
knee OA was signiﬁcantly associated with lower physical QOL
compared with radiographic knee OA without pain. We further
clariﬁed the independent associations with symptomatic knee OA
and grip strength. Symptomatic knee OA and grip strength were
independently associated with lower QOL.
In the present study, physical QOL was signiﬁcantly lower in
subjects with KL¼ 3 or 4 compared with KL¼ 0 or 1 as well as
KL¼ 2 in men and women. Samsa et al. reviewed the existing
literature and concluded that the Minimally Clinically Important
Difference (MCID) for the SF-36 is typically in the range of 3e5
points42, implying that differences in SF-36 scores of 1e2 points are
not important, but differences in scores of 3 points or more are
clinically important. In this study, differences of PCS scores
between subjects with KL¼ 3 or 4 and those with KL¼ 0 or 1 were
3.4 and 4.6 in men and women, respectively. The differences were
similar to MCID thresholds, indicating that KL¼ 3 or 4 knee OAmay
be clinically important for physical QOL. A previous study in ChinaDifference in means (95% CI)
L¼ 3 or 4 (N¼ 292) KL¼ v3 or 4 vs KL¼ 0 or 1 KL¼ 3 or 4 vs KL¼ 2
3.8 0.4 4.5 (5.7, 3.4) 3.0 (4.2, 1.9)
5.5 0.4 1.6 (2.9, 0.3) 1.9 (3.1, 0.7)
3.8 0.4 1.7 (0.7, 2.7) 1.4 (0.4, 1.5)
3.8 0.4 1.9 (0.7, 3.1) 1.3 (0.2, 2.4)
.85 0.01 0.07 (0.09, 0.04) 0.04 (0.07, 0.02)
.89 0.01 0.003 (0.04, 0.03) 0.02 (0.04, 0.01)
.62 0.15 1.65 (1.23, 2.08) 1.16 (0.74, 1.59)
.99 0.15 0.53 (0.07, 1.00) 0.80 (0.38, 1.21)
.14 0.08 0.59 (0.37, 0.81) 0.35 (0.12, 0.57)
.85 0.08 0.10 (0.15, 0.34) 0.16 (0.06, 0.39)
.32 0.47 5.91 (4.54, 7.28) 3.78 (2.40, 5.16)
.79 0.47 1.42 (0.04, 2.88) 2.17 (0.85, 3.50)
ge, BMI and grip strength.
Fig. 1. Mean scores and SE of the SF-8, EQ-5D, and WOMAC scales in men and womenwith symptomatic knee OA (N¼ 38 and 154, respectively), radiographic knee OAwithout pain
(N¼ 53 and 140, respectively), and no radiographic knee OA (N¼ 676 and 1065, respectively). Symptomatic knee OA was deﬁned as KL¼ 3 or 4 with knee pain, radiographic knee
OA without pain was deﬁned as KL¼ 3 or 4 without knee pain, and no radiographic knee OA was deﬁned as KL¼ 0, 1 or 2.
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those with mild knee OA14, although their subjects were recruited
from hospitals, so QOL parameters were not compared between
subjects with mild knee OA and those without knee OA. The
present study showed that there were no signiﬁcant differences
between subjects with KL¼ 2 and those with KL¼ 0 or 1. Consid-
ering the deﬁnitions of the KL grade, our ﬁndings may indicate that
osteophytosis and joint space narrowing, which are representative
features of knee OA, have a different impact on QOL. In other words,
osteophytosis may have aweak impact on QOL, whereas joint space
narrowing may have a strong impact.
Because QOL was shown to be strongly associated with pain, we
next compared the impact of radiographic knee OA with and
without pain on QOL. The present study showed that symptomatic
knee OA was signiﬁcantly associated with lower physical QOL than
radiographic knee OA without pain. Differences in PCS scores
among subjects with symptomatic knee OA and those without
radiographic knee OA without pain were 6.6 and 6.5 in men and
women, respectively. The differences were higher than the MCID;
thus, symptomatic knee OA is considered clinically important for
physical QOL. In addition, there were no signiﬁcant differences in
physical QOL between subjects with radiographic knee OA withoutpain and those without radiographic knee OA. This ﬁnding indi-
cates that loss of physical QOL was more strongly associated with
symptoms such as pain due to radiographic knee OA rather than
radiographic changes of the knee itself. In other words, QOL may
improve when pain is relieved by medical care, even if subjects
have radiographic knee OA.
As measured by MCS of the SF-8, knee OA was associated with
higher QOL scores in men and women, although it was also associ-
ated with lower PCS. Past studies also showed the dissociation
between PCS and MCS in knee OA43. Several factors may contribute
to thisphenomenon. First, theMCSquestionswithin theSF-8 include
generic questions about energy levels, feelings of being “down-
hearted and blue,” and interference in daily activities as a result of
emotional problems. These questions are less sensitive to the pres-
ence of mental health issues than disease-speciﬁc scales such as the
Kessler psychological distress scale44. In fact, psychological distress
has been shown to be signiﬁcantly more frequent in those with
arthritis than thosewithout it, although scores on theMCSwere not
signiﬁcantly different between these two groups45. Second, the
dissociation may be due to a disability paradox46, which suggests
that people with chronic disabilities report serious limitations in
activities of daily living and problems in performing social roles, yet
Table IV
Correlations of symptomatic knee OA and grip strength with scores of the SF-8, EQ-5D, and WOMAC scales
SF-8 EQ-5D WOMAC







6.64 (8.82, 4.46) 2.49 (0.77, 4.21) 0.10 (0.14, 0.05) 2.46 (1.78, 3.13) 0.83 (0.48, 1.18) 6.19 (3.95, 8.42)
Adjusted regression
coefﬁcient
6.00 (8.17, 3.81) 2.10 (0.33, 3.88) 0.08 (0.12, 0.03) 2.18 (1.51, 2.86) 0.75 (0.39, 1.10) 4.88 (2.67, 7.10)
Grip strength Crude regression
coefﬁcient
0.20 (0.15, 0.25) 0.03 (0.07, 0.01) 0.003 (0.002, 0.004) 0.06 (0.07, 0.04) 0.02 (0.03, 0.01) 0.23 (0.28, 0.17)
Adjusted regression
coefﬁcient







6.29 (7.42, 5.16) 2.66 (1.64, 3.69) 0.07 (0.10, 0.05) 2.05 (1.64, 2.47) 0.80 (0.59, 1.02) 6.74 (5.40, 8.08)
Adjusted regression
coefﬁcient
4.36 (5.52, 3.21) 2.52 (1.43, 3.61) 0.03 (0.06, 0.01) 1.44 (1.02, 1.85) 0.51 (0.29, 0.74) 3.97 (2.68, 5.27)
Grip strength Crude regression
coefﬁcient
0.34 (0.28, 0.41) 0.06 (0.01, 0.12) 0.007 (0.006, 0.009) 0.11 (0.13, 0.08) 0.04 (0.05, 0.03) 0.46 (0.53, 0.39)
Adjusted regression
coefﬁcient
0.20 (0.13, 0.27) 0.08 (0.01, 0.15) 0.004 (0.003, 0.006) 0.04 (0.07, 0.02) 0.01 (0.03, 0.00) 0.21 (0.30, 0.13)
Adjusted regression coefﬁcient is calculated by multiple regression analysis with age, BMI, grip strength, and the presence of symptomatic knee OA as independent variables.
SF-8, Medical Outcomes Study Short Form-8.
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OA had knee pain, which may lead to functional impairment.
Particularly in elderly individuals, pain or functional impairment
may be considered a natural consequence of being elderly. Knee OA
was thus not associated with lower scores for MCS in the SF-8.
In the present study, grip strength was independently associ-
ated with QOL measured by almost all domains of the three scales.
Previous reports showed that lowmuscle mass was associated with
reduced QOL32,33. There is increasing recognition that grip strength
is a useful clinical marker of sarcopenia, and recent work has
validated this approach, demonstrating that grip strength is more
strongly associated with age and is a better predictor of poor
mobility than other potential markers such as calf muscle area31.
The independent association of grip strength with QOL suggests
that QOL may improve with increase of muscle power in subjects
with symptomatic knee OA, although longitudinal studies will be
required to clarify this ﬁnding.
The present study showed that the association of radiographic
and symptomatic knee OA with QOL differed among the SF-8, the
WOMAC, and the EQ-5D. Radiographic and symptomatic knee OA
were signiﬁcantly associated with physical QOL in men and
women, but not with EQ-5D utility scores. The reason for this
difference may be explained by the fact that in the EQ-5D, all ﬁve
domains are combined to analyze the association with knee OA,
whereas the PCS and MCS of the SF-8 are analyzed separately. In
fact, associations of knee OA differed between PCS and MCS of the
SF-8, so when all domains were combined, the results may differ.
For WOMAC, previous studies have found that WOMAC discrimi-
nates better among individuals with knee OA, whereas the SF-36
discriminates better among individuals with varying levels of self-
reported general health status and comorbidities47. In addition,
WOMACwas shown to be amore responsive measure than SF-36 in
documenting changes after surgery7,10. Although our survey is not
strictly comparable in design, it would appear that in our Japanese
population, the PCS of the SF-8 and physical function domains of
the WOMAC are able to discriminate among individuals with knee
OA. It has been suggested that these two scales provide comple-
mentary information and may be useful in assessing both generic
and disease-speciﬁc aspects of OA. However, this was a cross-
sectional study, so the efﬁcacy of these scales for knee OA in
a longitudinal analysis could not be clariﬁed. In longitudinal
studies, generic measures such as the SF-8 may be much less usefulthan disease-speciﬁc measures such as the WOMAC because the
generic measures pick up a lot of “noise” from comorbidities and
may therefore be relatively unresponsive.
There are several limitations to the present study. First, this is
a large-scale, population-based study, with a cross-sectional study
of baseline data. Thus, causal relationships could not be determined.
The ROAD study is a longitudinal survey, so further progress may
help elucidate any causal relationships. Second, we did not include
other weight-bearing OAs, such as hip OA, in the analysis, although
this disordermay also affect QOL. However, the prevalence of KL¼ 3
or 4 hip was 1.4% and 3.5% in Japanese men and women48, respec-
tively, which was smaller compared with KL¼ 3 or 4 knee in the
present study. Thus it is possible that hip OA would not strongly
affect the results in the present study. Third, among the 2995
subjects 40 years old in the ROAD study, 2126 subjects had
completed questionnaires for the SF-8, the EQ-5D, and theWOMAC,
for a response rate of 71.0%. Subjects who completed questionnaires
may have had better QOL than those who did not, so our results
regarding QOL may have represented overestimations of QOL.
In conclusion, the present cross-sectional study using a large-
scale population from the ROAD study revealed that KL¼ 3 or 4 OA
was signiﬁcantly associated with lower physical QOL scores,
whereas KL¼ 2 OA was not. Symptomatic knee OA was more
strongly associated with QOL than radiographic knee OA without
pain. Further studies, along with continued longitudinal surveys in
the ROAD study, will help to elucidate the background of knee OA
and relations with QOL.
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